Back to User profile » Professor Hui Zhong Zhang
Papers published by Professor Hui Zhong Zhang:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
Wang CH, Liu LL, Liao DZ, Zhang MF, Fu J, Lu SX, Chen SL, Wang H, Cai SH, Zhang CZ, Zhang HZ, Yun JP
Cancer Management and Research 2018, 10:2241-2248
Published Date: 25 July 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection
Peng J, Li C, Wang F, Zhang H, Xiao W, Li H, Lu Z, Pan Z, Wu X, Zhang R
Cancer Management and Research 2018, 10:2095-2103
Published Date: 17 July 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
An increased number of negative lymph nodes is associated with a higher immune response and longer survival in colon cancer patients
He WZ, Xie QK, Hu WM, Kong PF, Yang L, Yang YZ, Jiang C, Yin CX, Qiu HJ, Zhang HZ, Zhang B, Xia LP
Cancer Management and Research 2018, 10:1597-1604
Published Date: 18 June 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality
Xie QK, He WZ, Hu WM, Yang L, Jiang C, Kong PF, Yang YZ, Yang Q, Zhang HZ, Zhang B, Xia LP
Cancer Management and Research 2018, 10:1365-1375
Published Date: 30 May 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Programmed death-ligand 1 expression correlates with diminished CD8+ T cell infiltration and predicts poor prognosis in anal squamous cell carcinoma patients
Zhao Y, Sun WP, Peng J, Deng Y, Fang Y, Huang J, Zhang H, Wan D, Lin J, Pan Z
Cancer Management and Research 2018, 10:1-11
Published Date: 18 December 2017